| SESSION 3: DIFFERENT CONTRACEPTIVE METHODS
(I.E. HORMONAL, IUDS, IMPLANTS) |
 |
||
| nr. | title | 1st
author |
abstract |
| P055 | Experience with Implanon in a North East London family planning clinic | S. Gupta (UK) | abstract |
| P056 | Progestogen only contraception and venous thromboembolism – is accepted clinical practice at odds
with manufacturer’s guidance? |
J. Brotherston (UK) | abstract |
| P057 | How late can you give Depo-medroxyprogesterone acetate? | S. Jones (UK) | abstract |
| P058 | Long-term safety and efficacy of extremely low-dose combined oral contraception containing 15 mg of
ethinylestradiol and 60 mg of gestodene |
D. Driák (Czech Republic) | abstract |
| P059 | An assessment of the infection risk associated with intrauterine device insertion in two different clinical
situations |
C. Johnman (UK) | abstract |
| P060 | A study on knowledge of women about condom and its relationship with the usage of condom in their
partners |
Z. Sooki (Iran) | abstract |
| P061 | Levonogestrel-releasing intrauterine devices: clinical experience and acceptability | M. Díaz-Vega (Spain) | abstract |
| P062 | A comparative study on the dislocation rate of the Mirena1 and the Multiload 3751 intrauterine device | G.S. Merki-Feld (Switzerland) | abstract |
| P063 | Transfallopian expulsion of IUCD – a case report | I. Samardziski (Macedonia) | abstract |
| P064 | Study of ovarian function in amenorrheic users of Mirena1 | I.C. Barbosa (Brazil) | abstract |
| P065 | Medical eligibility criteria for using modern oral contraceptives in women with type 1 diabetes | S.V. Nikitine (Russia) | abstract |
| P066 | Acceptability, safety and premenstrual symptomatology in women using an oral contraceptive
containing gestodene 60mcg/ethinylestradiol 15mcg |
I.C. Barbosa (Brazil) | abstract |
| P067 | Cycle control in women using an oral contraceptive containing gestodene 60mcg/ethinylestradiol
15mcg |
I.C. Barbosa (Brazil) | abstract |
| P068 | A survey of Norplant and DMPA: effects on women’s weight and blood pressure | Shohreh.ziaei (Iran) | abstract |
| P069 | Patient satisfaction and preference with the EVRA transdermal contraceptive patch compared to the
previous contraceptive method |
F. Weisberg (Canada) | abstract |
| P070 | NuvaRing improves cycle control in German women | S. Baumgaertner (Germany) | abstract |
| P071 | Acceptability and tolerability of NuvaRing in Ireland | S. Jones (UK) | abstract |
| P072 | The Mirena intrauterine system and user acceptability | J. Bowie (UK) | abstract |
| P073 | NuvaRing’s contraceptive efficacy and tolerability are comparable to an oral contraceptive | K. Oddsson (Iceland) | abstract |
| P074 | Satisfaction and compliance of 1333 users of transdermal contraception in private gynaecological
practice in Austria |
C.J. Gruber (Austria) | abstract |
| P075 | Sociodemographic properties and contraception use of pregnants before pregnancy | F. Altıntasoglu (Turkey) | abstract |
| P076 | Continued use of Implanon inserted following termination of pregnancy | M. Preston (UK) | abstract |
| P077 | Effect of Implanon1 on lumbar bone mineral density | B. Dilbaz (Turkey) | abstract |
| P078 | Effect of Implanon® on serum lipids, liver function tests and hemoglobin levels | B. Dilbaz (Turkey) | abstract |
| P079 | One year follow-up of patients on Implanon® for contraception: a multicentric prospective study | Y. Yakut (Turkey) | abstract |
| P080 | Vasectomy outcome of voluntary male surgical contraception at a metropolitan maternity hospital | B. Dilbaz (Turkey) | abstract |
| P081 | Vesical calculus formation around a migrated Copper-T 280a | S. Dede (Turkey) | abstract |
| P082 | Implanon: our three year experience | D. Sobral (Portugal) | abstract |
| P083 | The effects of increasing the copper load on IUD performance: a systematic review | P. O’Brien (UK) | abstract |
| P084 | The TCu380 Slimline or TCu380A: a systematic review of comparative data | P. O’Brien(UK) | abstract |
| P085 | The comparison of analgesic effects of local anesthesia and piroxicam in legal abortions | E.Z. Tuzcular Vural (Turkey) | abstract |
| P086 | The comparative trial of the effects on various parameters of two 30 µg EE monophasic oral
contraceptives containing 0.3 mg norgestrel and 0.075 mg gestodene |
E.Z. Tuzcular Vural (Turkey) | abstract |
| P087 | The experience with depot-medroxyprogesterone acetate used as a contraceptive method among
Turkish women |
Z. Vural (Turkey) | abstract |
| P088 | The frequency of complications in IUD users in family planning clinic, Shariati hospital, Tehran (1997–
2002) |
A. Hamid (Iran) | abstract |
| P089 | The colonization of IUDs with Actinomyces and other bacteriae | I. Gönenç (Turkey) | abstract |
| P090 | The effect of depot-medroxyprogesterone acetate on bone mineral density and lipid metabolism | I. Gönenç (Turkey) | abstract |
| P091 | Subdermal Implant: our experience in teenagers | A. Pereira (Portugal) | abstract |
| P092 | The effect of Implanon® and a non-medicated intrauterine device on the development of breastfed
infants |
S. Taneepanichskul (Thailand) | abstract |
| P093 | Satisfaction and non-contraceptive benefits with NuvaRing1, a novel vaginal combined contraceptive
method in a clinical experience program in Brazil |
N. de Melo (Brazil) | abstract |
| P094 | Ultrasonographic features of the endometrium and the ovaries in women on Implanon1 | T. Van den Bosch (Belgium) | abstract |
| P095 | Bacterial vaginal flora in Implanon users | G.G.G. Donders (Belgium) | abstract |
| P096 | Mechanical contraceptive methods and their complications in Iran | F. Hejazi (Iran) | abstract |
| P097 | Comparision of efficacy and complications of ınsertion of IUD in postplacental/postpartum period and
postpuerperal/ınterval period: 1 year follow-up* |
K. Eroglu (Turkey) | abstract |
|
|||